WinstonWınston
Abrdn Healthcare Investors logo

Abrdn Healthcare Investors

HQH
56
Asset Management · Financial Services
Price
$20.88
+0.03 (+0.14%)
Market Cap
$1.19B
Exchange
New York Stock Exchange
Winston Score
56
Winston is curious
A decent business — some strong pillars, some weaker.

Share count rising — dilution

+18.1% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 45.4M (2021) → 53.6M (2025)

Abrdn Healthcare Investors is a closed-end investment fund that pools money from investors and uses it to buy stocks and other securities in the healthcare industry. Its portfolio focuses on companies in areas like biotechnology, pharmaceuticals, medical devices, and healthcare services. The fund is managed by abrdn, a global asset management firm, and trades on the New York Stock Exchange under the ticker HQH.

The fund makes money by earning returns on its investments — through dividends, interest, and capital gains — and charges investors a management fee based on assets under management. It primarily invests in U.S. healthcare companies, though it may hold some international positions. Because it is a closed-end fund, its share price can trade at a discount or premium to the actual value of its holdings, which is a key risk for investors. The main growth driver is performance in the healthcare sector, while rising interest rates and biotech volatility remain the biggest ongoing risks.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+211.7% YoY

YoY Growth Rate

Revenue accelerating

EPS Growth

+99.4% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$0/ year

0.0% of revenue

Below sector average (7%)

Research and development spending

Insider Activity

0.0%ownership

Relatively low insider ownership

Cash Position

Cash flow positive

$1.1B cash & investments

Company generates more cash than it spends — no dilution risk from fundraising

Revenue accelerating

Abrdn Healthcare Investors grew revenue 212% year-over-year and the growth rate is speeding up. That's the kind of momentum growth investors look for — the question is whether margins can follow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
69.9%
Premium pricing power — 69.9% gross margin
Operating Margin
1018.5%
Excellent — 1018.5% operating margin
ROCE
15.9%
Strong — 15.9% return on capital

ROIC between 15% and 25%. Every dollar invested in the business earns 15 to 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
+89.7%
Fast-growing sales (89.7% YoY)
EPS YoY
N/A
Data not available
EPS Consistency
6/8 quarters
Earnings grew in most of the last 8 quarters

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
3%
Weak — only 3% of profit becomes cash
FCF Margin
26.9%
Converts sales into free cash efficiently (26.9%)

Free cash flow margin above 20%. Out of every $100 in sales, more than $20 is real cash they keep.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
N/A
Data not available
Interest Cover
100.00x
Comfortably covers interest (100.0x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
3.4x
Attractive valuation — P/E 3.4

P/E under 10. The price tag is small relative to last year's profit.

P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend Yield
11.03%
Healthy income — 11.03% yield

Yield above 6% — often a flag the market is pricing in a cut.

Dividend Growth
+0.0%
Dividend flat

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial